| Autor: |
Adeniji O; Department of Neurology, University College Hospital, Ibadan, Nigeria (O.A., R.A., M.O.)., Olowoyo P; Neurology Unit, Department of Medicine, Afe Babalola University Ado Ekiti, Nigeria (P.O.)., Akinyemi R; Department of Neurology, University College Hospital, Ibadan, Nigeria (O.A., R.A., M.O.).; Center for Genomic and Precision Medicine, University of Ibadan, Nigeria (R.A., M.O.)., Fisher M; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (M.F.)., Owolabi M; Department of Neurology, University College Hospital, Ibadan, Nigeria (O.A., R.A., M.O.).; Center for Genomic and Precision Medicine, University of Ibadan, Nigeria (R.A., M.O.). |
| Abstrakt: |
Competing Interests: M. Owolabi is supported by SIREN (U54HG007479), SIBS Genomics (R01NS107900), ARISES (R01NS115944–01), CANVAS (1R01NS114045-01), TALENTS (D43TW012030), and GRASP (UE5HL172183). M. Owolabi is an Associate Editor of Stroke. M. Owolabi reports employment by no commercial entity. Dr Fisher is a senior guest editor of Stroke and has received compensation from the American Heart Association (AHA). Dr Fisher reports compensation from Lumosa for consultant services; employment by Beth Israel Deaconess Medical Center; and compensation from Simcere USA for consultant services. The other authors report no conflicts. |
